基于LC-MS/MS和网络药理学的蒙药草果七味汤治疗失眠症的作用机制

    Mechanism of Mongolian Medicine Caoguo Qiwei Decoction in Treating Insomnia Based on LC-MS/MS and Network Pharmacology

    • 摘要:
      目的 鉴定蒙药草果七味汤的入血成分,并结合网络药理学、动物实验阐述其抗失眠症的潜在作用机制。
      方法 采用LC-MS/MS技术鉴定草果七味汤的化学成分及入血成分;在此基础上结合TCMSP、SwissTargetPrediction、GeneCards与OMIM数据库,筛选草果七味汤的成分靶点和失眠症的靶点,取交集获得抗失眠作用靶点;通过STRING数据库构建蛋白质-蛋白质相互作用网络;采用Cytoscape 3.10.0软件建立药物-成分-靶点-通路网络;利用Metascape平台进行GO功能和KEGG通路分析,预测草果七味汤治疗失眠的作用机制。为明确草果七味汤的抗失眠药效,将SD大鼠分为对照组、模型组、草果七味汤组和安神补脑液组。通过腹腔注射对氯苯丙氨酸进行造模,灌胃给药7 d后进行旷场实验,评估大鼠的一般状态和行为学改变,并使用LC-MS/MS法检测各组大鼠血清与脑组织中γ-氨基丁酸(gamma-aminobutyric acid,GABA)和多巴胺(dopamine,DA)含量;采用RT-qPCR检测大鼠脑组织中D2多巴胺受体(D2 dopamine receptor,DRD2)、GABRA2、GABRB3 mRNA表达水平。
      结果 从草果七味汤中鉴定出47个入血成分,网络药理学预测其关键成分pteryxin、dihydroartemisinin等可能作用于GABRB3、ADORA2A在内的193个共同靶点,并通过调控神经活性配体-受体相互作用、5-羟色胺能突触等信号通路发挥潜在作用。药效学实验结果显示,草果七味汤能显著改善失眠模型大鼠的行为学异常,升高脑组织与血清中GABA含量(P<0.05),并降低DA含量(P<0.05)。RT-qPCR结果显示,该方可有效降低脑组织中DRD2 mRNA表达水平(P<0.05),明显升高GABRA2和GABRB3 mRNA表达水平(P<0.05)。
      结论 本研究初步明确了草果七味汤的入血成分及潜在作用机制,为草果七味汤药理作用机制的进一步研究提供参考。

       

      Abstract:
      OBJECTIVE  To identify the absorbed components of the Mongolian medicine Caoguo Qiwei Decoction and elucidate its potential mechanism of action against insomnia through network pharmacology and animal experiments.
      METHODS LC-MS/MS technology was employed to identify the chemical constituents and absorbed components of the decoction. Based on this, the TCMSP, SwissTargetPrediction, GeneCards, and OMIM databases were used to screen for component-related and insomnia-related targets. The intersection of these two sets yielded anti-insomnia targets. Protein-protein interaction networks were constructed using the STRING database. A drug-active component-target-pathway network was established using Cytoscape 3.10.0 software. GO functional and KEGG pathway enrichment analyses were performed using the Metascape platform to predict the mechanism of action of Caoguo Qiwei Decoction in treating insomnia. To evaluate its anti-insomnia efficacy, SD rats were divided into 4 groups: a normal control group, a model group, a Caoguo Qiwei Decoction group, and a positive control group. The insomnia model was established via intraperitoneal injection of para-chlorophenylalanine. After 7 d of intragastric administration, open-field tests were conducted to assess the general status and behavioral changes. Serum and brain tissue levels of gamma-aminobutyric acid(GABA) and dopamine(DA) were measured in each group using LC-MS/MS. The mRNA expression levels of D2 dopamine receptor(DRD2), GABRA2 and GABRB3 in rat brain tissues were detected by RT-qPCR.
      RESULTS  A total of 47 absorbed components were identified in Caoguo Qiwei Decoction. Network pharmacology predicted that key components such as pteryxin and dihydroartemisinin might act on 193 common targets, including GABRB3 and ADORA2A, and exert potential effects by regulating signaling pathways such as neuroactive ligand-receptor interactions and serotonergic synapses. Pharmacodynamic experiments demonstrated that the decoction significantly ameliorated behavioral abnormalities in rats with insomnia, elevated GABA and reduced DA levels in brain tissue and serum(P<0.05). RT-qPCR results showed that the decoction could significantly downregulate the mRNA expression of DRD2(P<0.05) and markedly upregulate the mRNA levels of GABRA2 and GABRB3(P<0.05) in rat brain tissues.
      CONCLUSION  This study preliminarily clarified the absorbed components and potential mechanism of action of Caoguo Qiwei Decoction, providing a reference for further research on its pharmacological mechanism.

       

    /

    返回文章
    返回